| Trial ID: | L1217 |
| Source ID: | NCT00143741
|
| Associated Drug: |
Atorvastatin (Lipitor)
|
| Title: |
Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End-Stage Kidney Disease
|
| Interventions: |
DRUG: Atorvastatin (Lipitor)
|
| Outcome Measures: |
Primary: This study is to identify subjects who are highly sensitized with these antibodies, and treat them in such a way, that it may become possible to transplant kidneys into them., 6 months |
|
| Sponsor/Collaborators: |
Sponsor: University of Chicago
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-05
|
| Completion Date: |
2011-07
|
| Results First Posted: |
|
| Last Update Posted: |
2013-01-10
|
| Locations: |
The University of Chicago, Chicago, Illinois, 60637, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00143741
|
